Skip to main content
2026 CRT Conference Main banner

CRT 2026

Innovation and Technology

Session:: Valve and Structural Innovation Pipeline [Non-CME]

The Occlutech Atrial Flow Regulator (AFR) for Pulmonary Hypertension and Heart Failure

Tuesday, March 10, 2026
9:40 AM - 9:48 AM EST
Location: International Ballroom West

    Speaker(s)

  • Hans R. Figulla, MD, PhD

    Full Professor emeritus
    Universitätsklinikum Jena
    Jena, Thuringen, Germany

    Disclosure(s): ,Occlutech: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing); devie medical GmbH: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing); JenaValve Technology Inc: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing)

Disclosure(s):
Hans R. Figulla, MD, PhD: ,Occlutech: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing); devie medical GmbH: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing); JenaValve Technology Inc: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing)